Top 54 most influential individuals in India’s biopharma industry

After months of research and rounds of surveys , we have finalised the list of top 54 most influential individuals in India’s biopharma industry. Congratulations to our industry leaders from Biocon, Biological E, Dr Reddy’s Laboratories, Sun Pharma, Serum Institute of India, Cadila Healthcare, Lupin and many more. Simply click here to get your free copy of this ebook. You may also want …

Industry Insights: The World Biosimilar Congress 2015

Who is really impacted by healthcare spend? Is it the pharma companies investing millions in bringing drugs to market? The academics reliant on grants to provide research into new formulas and compounds? The service providers who rely on continued drug development and manufacturing to operate? Not exactly. At the end of the day, it’s the patients and their loved ones …

World Vaccine Congress 2015: Industry Insights

The World Vaccine Congress  is the  premier event in the vaccine calendar. It is the place where the vaccine industry meets to discuss scientific and commercial issues around vaccine research, development, manufacture and distribution. With only seven weeks to go till the event, we’re getting pretty excited and we hope you are too!  We’ve been in touch with a few of our …

Ebook: Your essential guide on trends, regulations and new technologies in Drug Safety

Drug safety must continue to evolve to meet heightened patient expectations and the fluctuating regulatory climate. It is becoming critical to exploit opportunities offered by emerging technologies, big data and personalised healthcare. To succeed in this new environment, we need to assess the regulatory updates; we need to examine how to implement regulations strategically and operationally in addition to discussing …

Industry Insights: European Antibody Congress 2015

The past year has been hugely defining in the discovery and development of therapeutics antibodies. From huge advances in cancer therapies and immune system modulation to recent developments in immunotherapy, neurological applications, treating infectious disease to creating vaccines: antibody based drugs are set to have profound effects in every area of medicine in the very near future. Covering everything from …

insights, ebook, evidence, real world evidence, rwe, evidence europe 2015

Ebook: Essential insights into real world evidence

Successful companies need to incorporate real world evidence in clinical trials, post approval studies and in payer engagement programmes. Needless to say, this shift is causing monumental changes in how the industry operates, how the payers engage with them and how service providers support pharma. This raises some important questions. What is value? What parts of our existing business model do we keep and what …

Download ebook: Your Patent Expiry Update – 2014 and beyond

Patent expiry has increasingly proved problematic for the Pharma industry. Whilst blockbuster drugs lose their patent protection and companies suffer losses in brand spending, generics steal the market with cheap, accessible, copycat alternatives.  While products worth $66 billion will lose protection in 2015, companies grasp on to their patents insisting they promise innovation and aid invention. The debate over the …

Download Ebook: 5 breakthrough therapies to watch

The US FDA’s Breakthrough Therapy demands sufficient preliminary clinical evidence to prove a compelling proof-of-concept; for instance the drug must show substantial improvement on a significant clinical endpoint when compared with current therapies. If these criteria are met, the US FDA is able to expedite the development and review of drug candidates that are able to treat serious of life …

market access, drug value, healthcare, evidence, ebook, market access usa

Download ebook: Essential Insights on demonstrating drug value in a challenging market

    How are pharma, payers and patients utilizing evidence of real world outcomes to better understand and demonstrate drug value and improve patient care? How is the global market access environment changing and how is this impacting on pharmaceutical organisations? What does pharma need to know about the diverse payer landscape, alternative payment plans and communicating and influencing decision making? These are some important questions …